NO321343B1 - Pulver av reverserte vesikler, fremgangsmater for fremstilling av pulveret og en dispersjon derav, samt en blanding fremstilt med pulveret - Google Patents
Pulver av reverserte vesikler, fremgangsmater for fremstilling av pulveret og en dispersjon derav, samt en blanding fremstilt med pulveret Download PDFInfo
- Publication number
- NO321343B1 NO321343B1 NO19985212A NO985212A NO321343B1 NO 321343 B1 NO321343 B1 NO 321343B1 NO 19985212 A NO19985212 A NO 19985212A NO 985212 A NO985212 A NO 985212A NO 321343 B1 NO321343 B1 NO 321343B1
- Authority
- NO
- Norway
- Prior art keywords
- powder
- vesicles
- dispersion
- weight
- reversed
- Prior art date
Links
- 239000006185 dispersion Substances 0.000 title claims abstract description 42
- 239000000843 powder Substances 0.000 title claims abstract description 30
- 239000000203 mixture Substances 0.000 title claims abstract description 22
- 238000000034 method Methods 0.000 title claims description 19
- 239000002736 nonionic surfactant Substances 0.000 claims abstract description 11
- 239000012867 bioactive agent Substances 0.000 claims abstract description 10
- 150000001875 compounds Chemical class 0.000 claims description 14
- 229920002545 silicone oil Polymers 0.000 claims description 12
- 230000000087 stabilizing effect Effects 0.000 claims description 12
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 12
- -1 fatty acid ester Chemical class 0.000 claims description 11
- 239000003921 oil Substances 0.000 claims description 10
- 235000014113 dietary fatty acids Nutrition 0.000 claims description 9
- 229930195729 fatty acid Natural products 0.000 claims description 9
- 239000000194 fatty acid Substances 0.000 claims description 9
- 238000002360 preparation method Methods 0.000 claims description 8
- 239000004094 surface-active agent Substances 0.000 claims description 8
- 238000001704 evaporation Methods 0.000 claims description 6
- 230000008020 evaporation Effects 0.000 claims description 6
- 150000002402 hexoses Chemical class 0.000 claims description 6
- 150000002972 pentoses Chemical class 0.000 claims description 6
- 229930006000 Sucrose Natural products 0.000 claims description 5
- 238000004519 manufacturing process Methods 0.000 claims description 5
- 239000005720 sucrose Substances 0.000 claims description 5
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims description 4
- 125000004178 (C1-C4) alkyl group Chemical group 0.000 claims description 2
- 230000000975 bioactive effect Effects 0.000 claims description 2
- 239000003039 volatile agent Substances 0.000 claims 2
- 239000000546 pharmaceutical excipient Substances 0.000 abstract description 5
- 230000003019 stabilising effect Effects 0.000 abstract 1
- ALYNCZNDIQEVRV-UHFFFAOYSA-N 4-aminobenzoic acid Chemical compound NC1=CC=C(C(O)=O)C=C1 ALYNCZNDIQEVRV-UHFFFAOYSA-N 0.000 description 14
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 8
- 235000019198 oils Nutrition 0.000 description 8
- 229960004050 aminobenzoic acid Drugs 0.000 description 7
- 238000001816 cooling Methods 0.000 description 7
- 238000005538 encapsulation Methods 0.000 description 7
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 6
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 6
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 4
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 4
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 4
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerol Natural products OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 4
- 239000005642 Oleic acid Substances 0.000 description 4
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 4
- 235000019483 Peanut oil Nutrition 0.000 description 4
- ZPVGIKNDGJGLCO-VGAMQAOUSA-N [(2s,3r,4s,5s,6r)-2-[(2s,3s,4s,5r)-3,4-dihydroxy-2,5-bis(hydroxymethyl)oxolan-2-yl]-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl] hexadecanoate Chemical compound CCCCCCCCCCCCCCCC(=O)O[C@@]1([C@]2(CO)[C@H]([C@H](O)[C@@H](CO)O2)O)O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O ZPVGIKNDGJGLCO-VGAMQAOUSA-N 0.000 description 4
- 239000000969 carrier Substances 0.000 description 4
- 239000003795 chemical substances by application Substances 0.000 description 4
- 235000012000 cholesterol Nutrition 0.000 description 4
- POULHZVOKOAJMA-UHFFFAOYSA-N dodecanoic acid Chemical compound CCCCCCCCCCCC(O)=O POULHZVOKOAJMA-UHFFFAOYSA-N 0.000 description 4
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 4
- 150000002430 hydrocarbons Chemical class 0.000 description 4
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 4
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 4
- 235000021313 oleic acid Nutrition 0.000 description 4
- 239000000312 peanut oil Substances 0.000 description 4
- 238000003860 storage Methods 0.000 description 4
- 239000004359 castor oil Substances 0.000 description 3
- 235000019438 castor oil Nutrition 0.000 description 3
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 238000002390 rotary evaporation Methods 0.000 description 3
- 229920006395 saturated elastomer Polymers 0.000 description 3
- 238000001694 spray drying Methods 0.000 description 3
- 238000003756 stirring Methods 0.000 description 3
- 238000009210 therapy by ultrasound Methods 0.000 description 3
- 235000015112 vegetable and seed oil Nutrition 0.000 description 3
- 239000008158 vegetable oil Substances 0.000 description 3
- 239000004215 Carbon black (E152) Substances 0.000 description 2
- SRBFZHDQGSBBOR-IOVATXLUSA-N D-xylopyranose Chemical compound O[C@@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-IOVATXLUSA-N 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- 239000005639 Lauric acid Substances 0.000 description 2
- 244000027321 Lychnis chalcedonica Species 0.000 description 2
- 235000021314 Palmitic acid Nutrition 0.000 description 2
- 235000021355 Stearic acid Nutrition 0.000 description 2
- SZYSLWCAWVWFLT-UTGHZIEOSA-N [(2s,3s,4s,5r)-3,4-dihydroxy-5-(hydroxymethyl)-2-[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxolan-2-yl]methyl octadecanoate Chemical compound O([C@@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@]1(COC(=O)CCCCCCCCCCCCCCCCC)O[C@H](CO)[C@@H](O)[C@@H]1O SZYSLWCAWVWFLT-UTGHZIEOSA-N 0.000 description 2
- YZXBAPSDXZZRGB-DOFZRALJSA-N arachidonic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O YZXBAPSDXZZRGB-DOFZRALJSA-N 0.000 description 2
- 238000000889 atomisation Methods 0.000 description 2
- 125000004432 carbon atom Chemical group C* 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 239000002537 cosmetic Substances 0.000 description 2
- UKMSUNONTOPOIO-UHFFFAOYSA-N docosanoic acid Chemical compound CCCCCCCCCCCCCCCCCCCCCC(O)=O UKMSUNONTOPOIO-UHFFFAOYSA-N 0.000 description 2
- SNRUBQQJIBEYMU-UHFFFAOYSA-N dodecane Chemical compound CCCCCCCCCCCC SNRUBQQJIBEYMU-UHFFFAOYSA-N 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 150000004665 fatty acids Chemical class 0.000 description 2
- 239000011521 glass Substances 0.000 description 2
- 229930195733 hydrocarbon Natural products 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 239000004570 mortar (masonry) Substances 0.000 description 2
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 2
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 2
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 2
- 235000019629 palatability Nutrition 0.000 description 2
- 239000002245 particle Substances 0.000 description 2
- 238000001907 polarising light microscopy Methods 0.000 description 2
- 229920000728 polyester Polymers 0.000 description 2
- 235000003441 saturated fatty acids Nutrition 0.000 description 2
- 150000004671 saturated fatty acids Chemical class 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 239000008117 stearic acid Substances 0.000 description 2
- TUNFSRHWOTWDNC-HKGQFRNVSA-N tetradecanoic acid Chemical compound CCCCCCCCCCCCC[14C](O)=O TUNFSRHWOTWDNC-HKGQFRNVSA-N 0.000 description 2
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 2
- 150000004670 unsaturated fatty acids Chemical class 0.000 description 2
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- 235000021357 Behenic acid Nutrition 0.000 description 1
- WQZGKKKJIJFFOK-QTVWNMPRSA-N D-mannopyranose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-QTVWNMPRSA-N 0.000 description 1
- IAYPIBMASNFSPL-UHFFFAOYSA-N Ethylene oxide Chemical group C1CO1 IAYPIBMASNFSPL-UHFFFAOYSA-N 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 238000012356 Product development Methods 0.000 description 1
- WPMWEFXCIYCJSA-UHFFFAOYSA-N Tetraethylene glycol monododecyl ether Chemical compound CCCCCCCCCCCCOCCOCCOCCOCCO WPMWEFXCIYCJSA-UHFFFAOYSA-N 0.000 description 1
- GCSPRLPXTPMSTL-IBDNADADSA-N [(2s,3r,4s,5s,6r)-2-[(2s,3s,4s,5r)-3,4-dihydroxy-2,5-bis(hydroxymethyl)oxolan-2-yl]-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl] dodecanoate Chemical compound CCCCCCCCCCCC(=O)O[C@@]1([C@]2(CO)[C@H]([C@H](O)[C@@H](CO)O2)O)O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O GCSPRLPXTPMSTL-IBDNADADSA-N 0.000 description 1
- UEYVMVXJVDAGBB-ZHBLIPIOSA-N [(2s,3s,4s,5r)-3,4-dihydroxy-5-(hydroxymethyl)-2-[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxolan-2-yl]methyl tetradecanoate Chemical compound O([C@@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@]1(COC(=O)CCCCCCCCCCCCC)O[C@H](CO)[C@@H](O)[C@@H]1O UEYVMVXJVDAGBB-ZHBLIPIOSA-N 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 238000005054 agglomeration Methods 0.000 description 1
- 230000002776 aggregation Effects 0.000 description 1
- WQZGKKKJIJFFOK-PHYPRBDBSA-N alpha-D-galactose Chemical compound OC[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-PHYPRBDBSA-N 0.000 description 1
- 239000008365 aqueous carrier Substances 0.000 description 1
- PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 description 1
- 235000021342 arachidonic acid Nutrition 0.000 description 1
- 229940114079 arachidonic acid Drugs 0.000 description 1
- 229940116226 behenic acid Drugs 0.000 description 1
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 239000000498 cooling water Substances 0.000 description 1
- 239000002577 cryoprotective agent Substances 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000008025 crystallization Effects 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 230000032050 esterification Effects 0.000 description 1
- 238000005886 esterification reaction Methods 0.000 description 1
- 150000002170 ethers Chemical class 0.000 description 1
- 150000002191 fatty alcohols Chemical class 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 229930182830 galactose Natural products 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 238000000265 homogenisation Methods 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- JCQLYHFGKNRPGE-FCVZTGTOSA-N lactulose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 JCQLYHFGKNRPGE-FCVZTGTOSA-N 0.000 description 1
- 229960000511 lactulose Drugs 0.000 description 1
- PFCRQPBOOFTZGQ-UHFFFAOYSA-N lactulose keto form Natural products OCC(=O)C(O)C(C(O)CO)OC1OC(CO)C(O)C(O)C1O PFCRQPBOOFTZGQ-UHFFFAOYSA-N 0.000 description 1
- 238000012792 lyophilization process Methods 0.000 description 1
- 239000000845 maltitol Substances 0.000 description 1
- VQHSOMBJVWLPSR-WUJBLJFYSA-N maltitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O VQHSOMBJVWLPSR-WUJBLJFYSA-N 0.000 description 1
- 229940035436 maltitol Drugs 0.000 description 1
- 235000010449 maltitol Nutrition 0.000 description 1
- WWZKQHOCKIZLMA-UHFFFAOYSA-N octanoic acid Chemical compound CCCCCCCC(O)=O WWZKQHOCKIZLMA-UHFFFAOYSA-N 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 239000008159 sesame oil Substances 0.000 description 1
- 235000011803 sesame oil Nutrition 0.000 description 1
- 125000005480 straight-chain fatty acid group Chemical group 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 231100000563 toxic property Toxicity 0.000 description 1
- 150000003626 triacylglycerols Chemical class 0.000 description 1
- LADGBHLMCUINGV-UHFFFAOYSA-N tricaprin Chemical compound CCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCC)COC(=O)CCCCCCCCC LADGBHLMCUINGV-UHFFFAOYSA-N 0.000 description 1
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Liposomes
- A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers
- A61K9/1272—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers with substantial amounts of non-phosphatidyl, i.e. non-acylglycerophosphate, surfactants as bilayer-forming substances, e.g. cationic lipids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Liposomes
- A61K9/1277—Processes for preparing; Proliposomes
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Dispersion Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Cosmetics (AREA)
- Medicinal Preparation (AREA)
- Emulsifying, Dispersing, Foam-Producing Or Wetting Agents (AREA)
- Medicines Containing Plant Substances (AREA)
- Manufacturing Of Micro-Capsules (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Materials For Medical Uses (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Detergent Compositions (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Seasonings (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP96201290 | 1996-05-10 | ||
PCT/EP1997/002598 WO1997042937A1 (fr) | 1996-05-10 | 1997-05-12 | Produit vesiculaire instantane |
Publications (3)
Publication Number | Publication Date |
---|---|
NO985212L NO985212L (no) | 1998-11-09 |
NO985212D0 NO985212D0 (no) | 1998-11-09 |
NO321343B1 true NO321343B1 (no) | 2006-05-02 |
Family
ID=8223974
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO19985212A NO321343B1 (no) | 1996-05-10 | 1998-11-09 | Pulver av reverserte vesikler, fremgangsmater for fremstilling av pulveret og en dispersjon derav, samt en blanding fremstilt med pulveret |
Country Status (24)
Country | Link |
---|---|
US (2) | US20090291105A1 (fr) |
EP (1) | EP0909164B1 (fr) |
JP (2) | JP4263771B2 (fr) |
AT (1) | ATE222486T1 (fr) |
AU (1) | AU706076B2 (fr) |
BG (1) | BG63659B1 (fr) |
CA (1) | CA2253358C (fr) |
CZ (1) | CZ292346B6 (fr) |
DE (1) | DE69714847T2 (fr) |
DK (1) | DK0909164T3 (fr) |
EA (1) | EA001116B1 (fr) |
ES (1) | ES2182076T3 (fr) |
HU (1) | HU225106B1 (fr) |
IS (1) | IS1996B (fr) |
NO (1) | NO321343B1 (fr) |
NZ (1) | NZ331693A (fr) |
PL (1) | PL187045B1 (fr) |
PT (1) | PT909164E (fr) |
SI (1) | SI0909164T1 (fr) |
SK (1) | SK283405B6 (fr) |
TR (1) | TR199802278T2 (fr) |
UA (1) | UA70286C2 (fr) |
WO (1) | WO1997042937A1 (fr) |
ZA (1) | ZA974083B (fr) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NZ331693A (en) * | 1996-05-10 | 2000-04-28 | Yamanouchi Europ Bv | reversed vesicules containing powder having one or more non ionic surfactant |
FR2936704B1 (fr) * | 2008-10-03 | 2011-01-07 | Bcm Cosmetique | Composition cosmetique de base comprenant une dispersion de vesicules inversees destinee a incorporer des principes actifs hydrophiles dans des compositions de maquillage. |
JP6242581B2 (ja) * | 2013-04-01 | 2017-12-06 | ポーラ化成工業株式会社 | 逆ベシクル組成物の製造方法 |
WO2014103742A1 (fr) * | 2012-12-25 | 2014-07-03 | ポーラ化成工業株式会社 | Composition vésiculaire réversible et son procédé de fabrication |
JP6239822B2 (ja) * | 2012-12-27 | 2017-11-29 | ポーラ化成工業株式会社 | 逆ベシクル組成物 |
WO2022107622A1 (fr) * | 2020-11-20 | 2022-05-27 | 株式会社カネカ | Nanodisque inverse |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE4021083C2 (de) * | 1990-07-03 | 1995-08-17 | Hans Dr Lautenschlaeger | Phospholipidformulierungen und ihre Verwendung für die Zubereitung liposomaler medizinischer und kosmetischer Bäder |
EP0521562B1 (fr) * | 1991-06-26 | 2003-03-05 | Yamanouchi Europe B.V. | Vésicules dans des milieux non-polaires |
AU7384994A (en) * | 1993-08-06 | 1995-02-28 | Opperbas Holding B.V. | A method for high loading of vesicles with biopolymeric substances |
GB9323588D0 (en) * | 1993-11-16 | 1994-01-05 | Cortecs Ltd | Hydrophobic preparation |
PL178394B1 (pl) * | 1994-02-04 | 2000-04-28 | Scotia Lipidteknik Ab | Lipofilowy preparat nośnikowy i środek farmaceutyczny zawierający lipofilowy preparat nośnikowy |
IT1269569B (it) * | 1994-04-22 | 1997-04-08 | Ugo Citernesi | Procedimento per la preparazione di complessi fra fosfolipidi e principi attivi utili per la produzione di liposomi e principi attivi e liposomi ottenuti con il procedimento |
US5693516A (en) * | 1995-11-27 | 1997-12-02 | Novo Nordisk Biotech, Inc. | Method for solubilizing proteins in organic solvents |
NZ331693A (en) * | 1996-05-10 | 2000-04-28 | Yamanouchi Europ Bv | reversed vesicules containing powder having one or more non ionic surfactant |
DE19713096A1 (de) * | 1997-03-27 | 1998-10-01 | Sueddeutsche Kalkstickstoff | Ölfreie Glycerophospholipid-Formulierungen und Verfahren zu deren Herstellung |
-
1997
- 1997-05-12 NZ NZ331693A patent/NZ331693A/xx not_active IP Right Cessation
- 1997-05-12 EA EA199800997A patent/EA001116B1/ru not_active IP Right Cessation
- 1997-05-12 SI SI9730337T patent/SI0909164T1/xx unknown
- 1997-05-12 TR TR1998/02278T patent/TR199802278T2/xx unknown
- 1997-05-12 DK DK97923963T patent/DK0909164T3/da active
- 1997-05-12 WO PCT/EP1997/002598 patent/WO1997042937A1/fr active IP Right Grant
- 1997-05-12 ZA ZA974083A patent/ZA974083B/xx unknown
- 1997-05-12 HU HU9903958A patent/HU225106B1/hu not_active IP Right Cessation
- 1997-05-12 DE DE69714847T patent/DE69714847T2/de not_active Expired - Lifetime
- 1997-05-12 CA CA002253358A patent/CA2253358C/fr not_active Expired - Fee Related
- 1997-05-12 AT AT97923963T patent/ATE222486T1/de active
- 1997-05-12 PT PT97923963T patent/PT909164E/pt unknown
- 1997-05-12 AU AU29590/97A patent/AU706076B2/en not_active Ceased
- 1997-05-12 SK SK1513-98A patent/SK283405B6/sk not_active IP Right Cessation
- 1997-05-12 EP EP97923963A patent/EP0909164B1/fr not_active Expired - Lifetime
- 1997-05-12 ES ES97923963T patent/ES2182076T3/es not_active Expired - Lifetime
- 1997-05-12 PL PL97329764A patent/PL187045B1/pl not_active IP Right Cessation
- 1997-05-12 JP JP54054497A patent/JP4263771B2/ja not_active Expired - Fee Related
- 1997-05-12 CZ CZ19983624A patent/CZ292346B6/cs not_active IP Right Cessation
- 1997-12-05 UA UA98126510A patent/UA70286C2/uk unknown
-
1998
- 1998-09-09 IS IS4845A patent/IS1996B/is unknown
- 1998-11-09 BG BG102909A patent/BG63659B1/bg unknown
- 1998-11-09 NO NO19985212A patent/NO321343B1/no not_active IP Right Cessation
-
2008
- 2008-10-22 JP JP2008272186A patent/JP2009062386A/ja not_active Withdrawn
- 2008-11-26 US US12/324,177 patent/US20090291105A1/en not_active Abandoned
-
2011
- 2011-03-11 US US13/046,285 patent/US20120039948A1/en not_active Abandoned
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU648573B2 (en) | Self-emulsifying glasses | |
US6652880B1 (en) | Oral pharmaceutical compositions containing long-chain triglycerides and liphophilic surfactants | |
US5096629A (en) | Method for preparing lipid powder for use in preparing liposomes and method for preparing liposomes | |
US20120039948A1 (en) | Instant Vesicular Product | |
NO168154B (no) | Fremgangsmaate for fremstilling av unilamellaere liposomer | |
JPH09508415A (ja) | 親油性担体製剤 | |
NO303205B1 (no) | FremgangsmÕte for fremstilling av lipidkompleksoppslemming | |
CA2375371A1 (fr) | Compositions a noyau huileux destinees a la liberation prolongee de medicaments hydrophobes | |
CN101584663A (zh) | 新型的注射用多西他赛脂质体给药系统及其制备方法 | |
JPS61207324A (ja) | リポソ−ム | |
IE913246A1 (en) | Lipid Formulation Systems | |
JP3187622B2 (ja) | リポソーム | |
JP3609827B2 (ja) | 非極性基剤における小胞 | |
JP2942556B2 (ja) | シクロスポリンを含有する新規組成物 | |
KR100468226B1 (ko) | 순간소포생성물 | |
Banerjee et al. | Application of self nano emulsifying drug delivery system for clarithromycin | |
Shahane et al. | PHARMACOSOMES: A NOVEL APPROACH FOR DRUG DELIVERY. | |
JPH01117824A (ja) | リポソームの製法 | |
JPS58152812A (ja) | 水性相中単層脂質顆粒の製造方法 | |
NL8102794A (nl) | Werkwijze voor het bereiden van een dispersie van kleine bolvormige deeltjes. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM1K | Lapsed by not paying the annual fees |